Long-term Cardiovascular Risk in Cured Cushing's Patients

Cushing's Disease Clinical Trial

Official title:

Role of Adipokines in Long-term Cardiovascular Risk in Cured Cushing's Patients

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00881283
• Other study ID #: 2008-p-001379
• Status: Terminated
• Start date: September 8, 2008
• Est. completion date: March 30, 2010

Study information

• Verified date: August 2020
• Source: Massachusetts General Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine whether subjects who have been affected by Cushing's disease in the past maintain some different characteristics compared with subjects who have never been diagnosed with the disease.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 1
• Est. completion date: March 30, 2010
• Est. primary completion date: March 30, 2010
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 35 Years to 55 Years

Eligibility

Inclusion Criteria:

• patients who have been cured of Cushing's disease at least 5 years ago.

Exclusion Criteria:

• patients who have been cured of Cushing's disease more than 15 years ago.

Related Conditions & MeSH terms

• ACTH-Secreting Pituitary Adenoma
• Cushing's Disease
• Pituitary ACTH Hypersecretion

Locations

Country	Name	City	State
United States	Neuroendocrine Clinical Center	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Massachusetts General Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	adipokine measurements		baseline